Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity

Mol Ther. 2021 Dec 1;29(12):3529-3533. doi: 10.1016/j.ymthe.2021.10.007. Epub 2021 Oct 27.
No abstract available

Publication types

  • Published Erratum